Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IBRX
#815
ImmunityBio, Inc. Common Stock
9.7
8
+3.93%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+3.93%
Variazione Mensile
+63.00%
Variazione di 6 mesi
+312.66%
Variazione Annuale
+213.46%
Chiusura Precedente
9.4
1
Open
9.7
8
Bid
Ask
Low
9.7
8
High
9.7
8
Volume
189
Mercati
Mercato Azionario Statunitense
Salute
IBRX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
696.83 M
853.44 M
882.62 M
945.25 M
984.97 M
1.03 B
—
Valuation ratios
Enterprise value
2.48 B
2.04 B
2.6 B
2.36 B
2.36 B
1.95 B
9.27 B
Price to earnings ratio
-4.09
-4.13
-5.28
-5.62
-6.15
-5.21
-22.26
Price to sales ratio
350.77
121.61
74.48
38.46
26.24
16.08
155.25
Price to cash flow ratio
-5.53
-4.58
-5.9
-5.82
-6.39
-5.97
-24.09
Price to book ratio
0.87
3.67
0.87
0.85
0.95
3.64
6.31
Enterprise value to EBITDA ratio
—
-6.25
-11.5
-21.29
-294.25
25.23
-301.82
Profitability ratios
Return on assets %
0.24
0.15
0.43
0.23
0.13
0.12
0.91
Return on equity %
0.12
0.12
0.22
0.16
0.13
0.12
0.63
Return on invested capital %
143.62
128.67
120.07
132.62
104.2
120.13
477.01
Gross margin %
100
100
99.65
99.49
99.45
99
397.58
Operating margin %
1 314.33
918.96
390.08
269.76
173.51
168.95
1 002.3
EBITDA margin %
-1 241.37
-864.17
62.06
75.77
84.08
86.25
308.16
Net margin %
1 404.01
783.4
784.92
350.26
209.77
161.8
1 506.74
Liquidity ratios
Quick ratio
2.64
3.21
2.05
3.98
5.65
5.08
16.76
Current ratio
2.68
3.36
2.22
4.11
5.77
5.1
17.19
Inventory turnover
0
0
0.01
0.02
0.03
0.1
0.15
Asset turnover
0.02
0.02
0.05
0.07
0.07
0.08
0.27
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
2.67
0.74
0.98
0.76
0.61
0.65
2.99
Long term debt to total equity ratio
1.31
0.58
0.5
0.54
0.6
0.65
2.29
Per share metrics
Operating cash flow per share
0.14
0.12
0.1
0.09
0.07
0.08
0.34
EBIT per share
-0.11
-0.1
0.01
0.02
0.02
0.03
0.08
EBITDA per share
-0.11
-0.09
0.01
0.02
0.03
0.04
0.1
Total debt per share
—
—
—
—
—
—
—
Cash per share
0.19
0.21
0.07
0.17
0.27
0.26
0.78
Net current asset value per share
0.23
0.26
0.13
0.23
0.35
0.34
1.05
Tangible book value per share
1.04
0.68
0.68
0.63
0.54
0.53
2.37
Working capital per share
0.15
0.19
0.07
0.18
0.29
0.28
0.81
Book value per share
1.07
0.7
0.69
0.64
0.55
0.54
2.43
Notizie
Simon, director, sells ImmunityBio (IBRX) shares worth $900k
ImmunityBio completes enrollment in bladder cancer trial
ImmunityBio Investors Rally Behind Cancer Trial Milestone - ImmunityBio (NASDAQ:IBRX)
Netflix and Palantir among market cap stock movers on Wednesday
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase - ImmunityBio (NASDAQ:IBRX)
AMD and Keysight Technologies among market cap stock movers on Tuesday
Tesla, Oracle among market cap stock movers on Monday
H.C. Wainwright raises Immunitybio stock price target to $15
ImmunityBio (IBRX) Reports Q4 Loss, Beats Revenue Estimates
American Express, Oracle among market cap stock movers on Monday
Immunitybio Inc earnings beat by $0.05, revenue topped estimates
ImmunityBio Shares Surge On 700% Revenue Growth Driven By Anktiva - ImmunityBio (NASDAQ:IBRX)